![](https://investorshub.advfn.com/uicon/496411.png?cb=1505403973)
Tuesday, October 04, 2022 7:50:10 PM
Regarding BOD approval.... look at her BOD -- think she would have ANY trouble getting them to sign off on a R/S when she wants one?
There will always be a market for shares in a zombie biotech like BIEL as long as they keep baking those sky pies. Look at all that pastry! RecoveryRx, Veterinary use, extra strength ActiPatch, migraines, ghost pain, Allay, more OEM Partners, more Distributors, etc etc etc....
Ahhhh yes, the sticky subject of A/S increases... if the Whelans had any experience in running a zombie biotech, they would have known that a couple reverse splits would have been preferable to letting the A/S bloat to 25 billion.
Yes, BIEL is a zombie biotech.
https://www.investopedia.com/terms/z/zombies.asp
https://capital.com/meet-living-dead-what-is-biotech-zombie-stock
https://www.biospace.com/article/walking-dead-biotech-zombie-companies-and-why-they-are-failing-/#:~:text=A%20%E2%80%9Czombie%20company%E2%80%9D%20is%20media,but%20not%20reduce%20its%20debts.
And tell me about this "public notice required for A/S increase." BIEL's past A/S increases were "public notice" after the fact, in the financial filings.
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM